Product

Products for Clinical Studies (without MA)

Radiopharmaceuticals

Products for clinical trials

[18F]PSMA-1007
Ligand of imaging of PSMA expression in vivo

  • Localisation of lesions of prostate cancer

[18F]FMISO
[18F]Fluoromisonidazole
Imaging of hypoxia in vivo

  • Assessment of tumor hypoxia as feature associated with therapeutic resistance
  • PET-guided radiotherapy
  • Evaluation of therapeutic response to antiangiogenic agents

[18F]Flumazenil
Imaging of GABA(A) receptors in vivo

  • Presurgical evaluation of temporal lobe epilepsy
  • Imaging the ischemic penumbra and assessment of therapeutic response

[18F]Fallypride
Imaging of D2/D3 receptors in vivo

  • Differential diagnosis of idiopathic parkinsonian syndrome (IPS, Parkinson’s disease) and atypical parkinsonian syndrome (APS)
  • Dose-finding PET occupancy studies of novel antipsychotics

[18F]FLT
[18F]3-deoxy-3-fluorothymidine
Imaging of cell proliferation in vivo

  • Pretherapeutic prognostic assessment
  • Evaluation of response to antitumour treatment

[18F]FES
[18F]Fluoroestradiol
Imaging of estrogen receptors in vivo

  • Predictive imaging of response to endocrine therapy in women with oestrogen receptor positive breast cancer
  • Detection of lesions of breast cancer when antioestrogene treatment is a therapeutic option

[18F]Mefway
Imaging of 5-HT1A receptors in vivo

  • Imaging of 5-HT1A receptors in anxiety disorders and depression
  • Drug development: Occupancy of agonist drugs at the 5-HT1A receptor

[68Ga]Nodaga-RGD
Ligand of integrin αv β3 for imaging of angiogenesis in vivo

  • Prediction of therapeutic response to therapeutic regimens including medicines with antiangiogenic effect

[68Ga]PSMA-11
Ligand of imaging of PSMA expression in vivo

  • Localisation of lesions of prostate cancer

[68Ga]DOTA-NOC
[68Ga]DOTA-1-Nal3-octreotide
Imaging of somatostatin receptors in vivo

  • Characterisation, localisation, staging and restating of gastroenteropancreatic neuroendocrine tumours
  • Detection of the primary occult neuroendocrine tumor when a metastasis of primary neuroendocrine tumor has been demonstrated or when the serum concentration of specific marker is increased

 

Therapeutic indications. This medicinal product is for diagnostic use only.

More innovative
products

01

Arrow Right

02

Arrow Right

04

Arrow Right

Do you want to know more about our products?

For inquiries please contact us, we will be happy to assist you!

Scroll to Top